Endocarditis Caused byStaphylococcus aureuswith Reduced Susceptibility to Vancomycin

Abstract
Clinical management of infective endocarditis (IE) is expected to become more difficult with the emergence of Staphylococcus aureus with reduced susceptibility to vancomycin (SARV) in the United States and worldwide. We report the strain characterization and treatment of a patient with SARV IE.

This publication has 21 references indexed in Scilit: